NSE filing, NSE: MKPL. Summary written from the filing by ALFA Finder's alert engine.
M K Proteins Ltd: key numbers
- Share price
- ₹3.76
- Market cap
- ₹141.1 Cr
- Revenue (annual)
- ₹382.9 Cr
- Net profit (annual)
- ₹6.83 Cr
- P/E (TTM)
- 30.0×Sector 40.4×
- Promoter holding
- 74.82%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from M K Proteins Ltd
All →M K Proteins Other Announcement
Standard quarterly shareholding pattern filing for M. K. Proteins Ltd for the quarter ended September 30, 2026.
M K Proteins Management Change
M. K. Proteins Ltd's shareholders approved the appointment of Ms. Aritika Garg as an Independent Director for a five-year term at the 14th AGM.
M K Proteins Annual General Meeting
M. K. Proteins Limited conducted its 14th Annual General Meeting on September 30, 2026. Shareholders considered financial statements, director appointments, and related party transaction approvals.
M K Proteins Other Announcement
M K Proteins Limited is providing the Annual Report for FY 2025-26 to shareholders via web links and QR codes, per Regulation 36(1)(b) of SEBI LODR.
M K Proteins Annual General Meeting
M K Proteins Limited has scheduled its 14th Annual General Meeting for September 30, 2026, and approved the associated notice and directors' report.
M K Proteins Management Change
M K Proteins Limited has appointed Ms. Aritika Garg as a Non-Executive Independent Director effective August 22, 2026.
Other board meeting date announcements
All →Everest Kanto Cylinder Board Meeting Date
Everest Kanto Cylinder gave notice of a board meeting on 13 November 2026 to approve unaudited standalone and consolidated results for the quarter and six months ended 30 September 2026. The trading window stays closed until 48 hours after results.
Omkar Pharmachem Board Meeting Date
Omkar Pharmachem intimates a board meeting on 14 November 2026 to approve unaudited results for the quarter and half year ended 30 September 2026. The trading window stays closed until 16 November 2026.
Tomorrow Technologies Global Innovations Board Meeting Date
Tomorrow Technologies Global Innovations will hold a board meeting on 13 November 2026 to approve unaudited results for the quarter and half year ended 30 September 2026. The trading window is closed until 16 November 2026.
Sreechem Resins Board Meeting Date
Sreechem Resins Limited has notified a board meeting on 13 November 2026 to consider unaudited financial results for the quarter and half year ended 30 September 2026. Trading window closure continues until 48 hours after results declaration.
Alpa Laboratories Board Meeting Date
ALPA Laboratories Limited has intimated a board meeting on 14 November 2026 to consider unaudited standalone and consolidated half-yearly results for the period ended September 2026. Trading window is closed from 1 October 2026 until 48 hours after results announcement.
Pilani Investment and Industries Corporation Board Meeting Date
Pilani Investment will hold a board meeting on 10 November 2026 to consider September quarter results. The trading window stays closed until 48 hours after results.